申请人:MISSION THERAPEUTICS LIMITED
公开号:US11370784B2
公开(公告)日:2022-06-28
The present invention relates to cyano-substituted-heterocycles of Formula (I) with activity as inhibitors of deubiquitilating enzymes, in particular, ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30), having utility in a variety of therapeutic areas including cancer and conditions involving mitochondrial dysfunction.
本发明涉及式(I)的氰基取代的杂环化合物,其具有作为去泛素化酶(特别是泛素 C 端水解酶 30 或泛素特异性肽酶 30 (USP30))抑制剂的活性,可用于各种治疗领域,包括癌症和涉及线粒体功能障碍的疾病。